Ocular Oncology and Treatments
Ocular Oncology and Treatments is a research topic within Ophthalmology. Science Explorer counts 19k research works in it since 1950. 13.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research, diagnosis, and treatment of ocular cancers, particularly uveal melanoma and retinoblastoma. It covers topics such as genetic mutations, metastatic disease, various treatment modalities including radiation therapy and intraocular chemotherapy, prognostic factors, and tumor classification.
- Uveal Melanoma
- Retinoblastoma
- Ocular Surface Neoplasia
- Metastatic Disease
- Choroidal Melanoma
- Genetic Mutations
- Radiation Therapy
- Prognostic Factors
- Intraocular Chemotherapy
- Tumor Classification
- Research works
- 19k fractional, since 1950
- In the world top 10%
- 2.6k per year above
- Top-10% rate
- 13.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ocular Oncology and Treatments research?
By volume, the United States and China publish the most (771 and 422 works in 2022–2025).
By volume, 2022–2025
- 1 United States 771 works
- 2 China 422 works
- 3 India 288 works
- 4 Germany 135 works
- 5 United Kingdom 130 works
- 6 Japan 106 works
- 7 Italy 97 works
- 8 France 81 works
- 9 Spain 74 works
- 10 Türkiye 74 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ocular Oncology and Treatments research?
By volume in 2022–2025, L V Prasad Eye Institute publishes the most Ocular Oncology and Treatments research, followed by All India Institute of Medical Sciences and Wills Eye Hospital.
By volume, 2022–2025
- 1 L V Prasad Eye InstituteIndia 31 works
- 2 All India Institute of Medical SciencesIndia 30 works
- 3 Wills Eye HospitalUnited States 28 works
- 4 Thomas Jefferson UniversityUnited States 23 works
- 5 Sun Yat-sen UniversityChina 20 works
- 6 Sankara NethralayaIndia 18 works
- 7 Beijing Tongren HospitalChina 17 works
- 8 Aravind Eye HospitalIndia 17 works
- 9 University of MiamiUnited States 17 works
- 10 Leiden University Medical CenterNetherlands 15 works
Who are the leading researchers in Ocular Oncology and Treatments?
The most-cited researchers publishing on Ocular Oncology and Treatments include Jost B. Jonas, Songhomitra Panda‐Jonas and Dirk Schadendorf.
- 1 Jost B. Jonas Germany 7.7k citations
- 2 Songhomitra Panda‐Jonas Germany 4.6k citations
- 3 Dirk Schadendorf Germany 4.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ocular Oncology and Treatments research done?
The largest centres of Ocular Oncology and Treatments research in 2022–2025 are Beijing (China), Philadelphia (United States), Shanghai (China) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Philadelphia and Hyderabad.
Largest cities, 2022–2025
Where it is the local speciality
- PhiladelphiaUS · 71.9 works9.2×
- HyderabadIN · 36.3 works6.4×
Location quotient: how much more of its research is in Ocular Oncology and Treatments than the world average.
Where is the best place to study Ocular Oncology and Treatments?
Among universities, judged by research, All India Institute of Medical Sciences, Thomas Jefferson University and University of Miami score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia | 61.9 | 4.8% | 16.7× | 30 | +155.1% |
| 2 | Thomas Jefferson UniversityUnited States | 57.8 | 12.0% | 38.8× | 22 | +42.0% |
| 3 | University of MiamiUnited States | 52.5 | 13.4% | 11.7× | 17 | -3.2% |
| 4 | Capital Medical UniversityChina | 41.7 | 7.1% | 8.3× | 14 | +50.8% |
| 5 | Sun Yat-sen UniversityChina | 39.4 | 14.3% | 4.1× | 20 | +17.7% |
| 6 | University College LondonUnited Kingdom | 37.6 | 15.3% | 3.2× | 13 | +51.4% |
| 7 | Harvard UniversityUnited States | 37.2 | 17.9% | 3.1× | 12 | +54.3% |
| 8 | Shanghai Jiao Tong UniversityChina | 33.5 | 21.9% | 1.5× | 10 | +85.8% |
| 9 | University of TorontoCanada | 30.6 | 22.2% | 2.1× | 9 | -1.0% |
| 10 | Cornell UniversityUnited States | 26.9 | 15.9% | 2.8× | 8 | +37.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ocular Oncology and Treatments research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Ocular Oncology and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.